Atlas Trials

A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Clinical trial NCT01847274 · COMPLETED

Trial details

NCT number
NCT01847274
Sponsor
Tesaro, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian NeoplasmsPlatinum Sensitive Ovarian Cancer
Start date
2013-06-21
Primary completion
2016-04-22
Enrollment
596

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.